Sufer®

Sufer®
Product Description

Sufer® is an intravenous iron preparation for rapid clinical and haematological correction of iron deficiency — twice faster compared to other types of iron preparations; by 25 % lower need for erythropoietin when administered concurrently with other medications. Active substance: 1 ml of the solution contains 20 mg of iron as iron (III) hydroxide-sucrose complex. Indications. Iron-deficiency conditions: ‒ for rapid replenishment of iron; ‒ patients who cannot tolerate oral iron preparations or fail to comply with their regular administration; ‒ for treatment of active inflammatory diseases of the digestive tract, when oral iron preparations are ineffective.

Yuria-Pharm

  • UA
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator

Yuria-Pharm

  • UA
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator

More Products from Yuria-Pharm (4)

  • Artro-Patch

    Product Artro-Patch

    ARTRO-PATCH is a biologically inert gel based on stabilized  hyaluronic acid, designed for intra-articular administration to  restore the visco-elastic properties of synovial fluid in traumatic and degenerative lesions of the synovial joints, manifested by pain syndrome and/or reduced mobility.
    ...
  • XAVRON

    Product XAVRON

    XAVRON – ischemic cascade blocker for the empirical therapy of acute ischemic stroke and transient ischemic attack. XAVRON contributes to the reduction of the area of ischemic injury and the absence of distant neurological consequences of stroke when applied in the early period. Active ingredient: 1 ...
  • Alexa Volume

    Product Alexa Volume

    Filler for deep wrinkles and volumetric correction of facial contours

    Science

    Titanium-niobium knives grind filler mass for maximum purity of filler.This helps prevent heavy metal particles from entering the gel

    Maximum particle size =...
  • Alexa Medium

    Product Alexa Medium

    Filler for correcting medium-depth wrinkles and lip augmentation

    Science

    Minimal risk of swelling at injection site: fluid cumulation/administered drug volume ratio is 1:1

    Maximum particle size = 600 μm17.5 mg/ml

    Results

    Corr...